Congenital abnormalities and assessment of fetal wellbeing
Congenital abnormalities
Fetal abnormality is found in:
• 15% of deaths between 20 weeks gestation and 1 year postnatal
• 1–2% of births, including major and minor anomalies (a major abnormality is an abnormality or abnormalities that result in the death of the baby or severe disability)
The overall incidence in the UK has fallen over the past three decades due to the introduction of screening programmes in pregnancy, the resultant greater success at diagnosis during pregnancy and parents opting to terminate a pregnancy once a severe abnormality has been diagnosed.
The commonest four groups of defects are neural tube defects (3–7/1000), congenital cardiac defects (6/1000), Down’s syndrome (1.5/1000) and cleft lip/palate (1.5/1000) (Table 10.1).
Table 10.1
Major congenital abnormalities
Abnormality | Approximate incidence (per 1000 births) |
Neural tube defects | 3–7 |
Congenital heart disease | 6 |
Severe mental retardation | 4 |
Down’s syndrome | 1.5 |
Cleft lip/palate | 1.5 |
Talipes | 1–2 |
Abnormalities of limbs | 1–2 |
Deafness | 0.8 |
Blindness | 0.2 |
Others, including urinary tract anomalies | 2 |
Total | 15–30 |
Neural tube defects
The neural tube defects are the commonest of the major congenital abnormalities and include anencephaly, microcephaly, spina bifida with or without myelomeningocele, encephalocele, holoprosencephaly and hydranencephaly (Fig. 10.1). The incidence is approximately 1/200 and the chance of having an affected child after one previous abnormal child is 1/20. Infants with anencephaly or microcephaly do not usually survive. Many die during labour and the remainder within the first week of life. Infants with open neural tube defects often survive, particularly where it is possible to cover the lesion surgically with skin. However, the defect may result in paraplegia and bowel and bladder incontinence. The child often has normal intelligence and becomes aware of the problems posed for the parents. Closed lesions generally do not cause problems and may escape detection until after birth.
Congenital cardiac defects
Some of these infants present with intrauterine growth retardation and oligohydramnios, but in many cases the diagnosis is recognised and diagnosed after delivery. With improvements in real-time ultrasound imaging, recognition of many cardiac defects has become possible; however, early recognition is essential if any action is to be taken. A four-chamber view of the fetal heart is shown in Figure 10.2.
Defects of the abdominal wall
Defects of the abdominal wall can be diagnosed by ultrasound imaging. They include gastroschisis and exomphalos (Fig. 10.3). In both cases, the bowel extrudes outside the abdominal cavity. The main differences between the two are that a gastroschisis is a defect that is separate from the umbilical cord (usually 2–3 cm below and to the right), does not have a peritoneal covering and is usually an isolated problem. In contrast, an exomphalos is essentially a large hernia of the umbilical cord with a peritoneal covering and an increased risk of an underlying chromosomal abnormality,
Chromosomal abnormalities
Down’s syndrome
Down’s syndrome (DS) is characterized by the typical abnormal facial features (Fig 10.4), mental retardation of varying degrees of severity and congenital heart disease. The karyotype includes an additional chromosome on group 21 (‘trisomy 21’; Fig 10.5). The incidence overall is 1.5/1000 births. However, the risk increases with advancing maternal age (see below). The underlying reason is thought to be an increased frequency of non-disjunction at meiosis.
Assessing fetal normality
Screening
Clinical risk factors: early pregnancy
• maternal age and risk of aneuploidy especially DS (see Tables 10.2 and 10.3).
Table 10.2
The risk of having a pregnancy affected by Down’s syndrome according to maternal age at the time of birth
Maternal age at delivery (years) | Risk of Down’s syndrome |
15 | 1 : 1578 |
20 | 1 : 1528 |
25 | 1 : 1351 |
30 | 1 : 909 |
31 | 1 : 796 |
32 | 1 : 683 |
33 | 1 : 574 |
34 | 1 : 474 |
35 | 1 : 384 |
36 | 1 : 307 |
37 | 1 : 242 |
38 | 1 : 189 |
39 | 1 : 146 |
40 | 1 : 112 |
41 | 1 : 85 |
42 | 1 : 65 |
43 | 1 : 49 |
44 | 1 : 37 |
45 | 1 : 28 |
46 | 1 : 21 |
47 | 1 : 15 |
48 | 1 : 11 |
49 | 1 : 8 |
50 | 1 : 6 |
Reproduced with permission from James D, Steer, P, Weiner, C, Gonik et al., eds. High Risk Pregnancy: Management Options, 4th edn. WB Saunders, © 2010 Elsevier.
Table 10.3
Chromosomal abnormalities by maternal age at the time of amniocentesis performed at 16 weeks’ gestation (expressed as rate per 1000)
Maternal age (years) | Trisomy 21 | Trisomy 18 | Trisomy 13 | XXY | All chromosomal anomalies |
35 | 3.9 | 0.5 | 0.2 | 0.5 | 8.7 |
36 | 5.0 | 0.7 | 0.3 | 0.6 | 10.1 |
37 | 6.4 | 1.0 | 0.4 | 0.8 | 12.2 |
38 | 8.1 | 1.4 | 0.5 | 1.1 | 14.8 |
39 | 10.4 | 2.0 | 0.8 | 1.4 | 18.4 |
40 | 13.3 | 2.8 | 1.1 | 1.8 | 23.0 |
41 | 16.9 | 3.9 | 1.5 | 2.4 | 29.0 |
42 | 21.6 | 5.5 | 2.1 | 3.1 | 37.0 |
43 | 27.4 | 7.6 | 4.1 | 45.0 | |
44 | 34.8 | 5.4 | 50.0 | ||
45 | 44.2 | 7.0 | 62.0 | ||
46 | 55.9 | 9.1 | 77.0 | ||
47 | 70.4 | 11.9 | 96.0 |
anticonvulsant drugs (e.g. phenytoin, carbamazepine and sodium valproate) that can produce defects of the central nervous system especially neural tube defects
cytotoxic agents used in cancer therapy or for immunosuppression with organ transplantation are associated with an increased risk of fetal growth restriction